Synthesis and antimalarial effects of 1-(3,4-dichlorophenyl)-3-(4-((1-ethyl-3-piperidyl)amino)-6-methyl-2-pyrimidinyl)guanidine and related substances.
D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000627:therapeutic use; D002645:Chickens; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000138:chemical synthesis / Q000627:therapeutic use; D004032:Diet; D006146:Guanidines / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000627:therapeutic use; D006168:Guinea Pigs; D000882:Haplorhini; D007279:Injections, Subcutaneous; D008288:Malaria / Q000188:drug therapy; D051379:Mice; D010880:Piperidines / Q000008:administration & dosage / Q000138:chemical synthesis / Q000627:therapeutic use; D010962:Plasmodium berghei; D011743:Pyrimidines / Q000008:administration & dosage / Q000138:chemical synthesis / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship
D000962:Antimalarials; D002722:Chlorobenzenes; D006146:Guanidines; D010880:Piperidines; D011743:Pyrimidines; C007349:1-(3,4-dichlorophenyl)-3-(4-((1-ethyl-3-piperidyl)amino)-6-methyl-2-pyrimidinyl)guanidine